| Metric | Current Period | Prior Year Period | YoY |
|---|---|---|---|
| Revenue / Net Sales | ¥731.6B | ¥588.5B | +24.3% |
| Operating Income / Operating Profit | ¥196.1B | ¥174.8B | +12.2% |
| Ordinary Income | ¥214.4B | ¥183.0B | +17.2% |
| Net Income / Net Profit | ¥143.4B | ¥126.2B | +13.7% |
| ROE | 17.4% | 18.6% | - |
For the FY2026 Q3 cumulative period (2025-08-01 to 2026-04-30), Revenue was ¥731.6B (¥588.5B in the prior year period, +¥143.1B +24.3%), Operating Income was ¥196.1B (¥174.8B, +¥21.3B +12.2%), Ordinary Income was ¥214.4B (¥183.0B, +¥31.4B +17.2%), and Net Income was ¥143.4B (¥126.2B, +¥17.2B +13.7%), marking four consecutive periods of revenue and profit growth. The core HRTech segment grew revenue by 22.0% and drove the overall performance, while the operating margin declined to 26.8% from 29.7% a year earlier (-2.9pt) as growth investments and an expanding loss in the Incubation business compressed margins. The high gross margin structure of 89.5% was maintained, but SG&A increased by +26.7% YoY, temporarily reducing operating leverage. At the ordinary income level, equity-method investment gains of ¥2.4B contributed, leading to outperformance versus operating income, and at the net income level, after a tax burden at an effective tax rate of 33.1%, the net margin was 19.6% (down 1.8pt from 21.4% prior year). Total assets were ¥1,125.2B, equity ratio 73.2%, and cash ¥729.3B, indicating a very solid financial base. Goodwill increased substantially by +¥102.4B to ¥139.8B, reflecting accelerated M&A-driven growth investment.
[Revenue] Revenue of ¥731.6B (+24.3%) was driven by the core HRTech segment at ¥693.7B (+22.0%), representing 94.8% of the total, supported by expanding hiring demand and deepening penetration with existing customers. The Incubation segment grew rapidly to ¥39.7B (+99.5%) but remained only 5.4% of the mix. Gross profit was ¥654.9B (gross margin 89.5%), remaining at a very high level; gross margin declined 1.7pt from 91.2% a year earlier, but the business model continues to benefit from scale economics. Regional breakdowns are not disclosed, but inter-segment sales expansion (¥0.7B prior year → ¥1.9B) suggests progress in cross-sell.
[Profitability] Operating Income was ¥196.1B (+12.2%), lagging revenue growth, with an operating margin of 26.8% down 2.9pt from 29.7% prior year. SG&A was ¥458.7B (SG&A ratio 62.7%, worsening 1.2pt from 61.5% prior year), reflecting expanded hiring, advertising, and development investment. Notably, the Incubation segment’s loss widened to ¥15.6B (prior year △¥11.7B), diluting the company-wide margin. By segment, HRTech recorded Operating Income of ¥223.6B (margin 32.2%) maintaining high profitability, while Incubation remains in an investment phase with margin △39.2%. Ordinary Income of ¥214.4B (+17.2%) benefited from ¥18.6B in non-operating income (equity-method investment gains ¥2.4B, other ¥0.7B), while non-operating expenses were minimal at ¥0.3B (interest expense ¥0.04B, forex losses ¥0.15B, etc.), resulting in a +9.3% uplift vs. Operating Income. Net Income of ¥143.4B (+13.7%) is after income taxes of ¥71.0B (effective tax rate 33.1%) and non-controlling interests of ¥1.2B from pretax income of ¥214.4B, yielding a net margin of 19.6% (down 1.8pt). Special gains of ¥0.2B were immaterial; the quality of earnings is centered on recurring income. In conclusion, Visional achieved revenue and profit growth, though margin compression occurred temporarily due to accelerated growth investment.
The HRTech segment reported Revenue ¥693.7B (+22.0%), Operating Income ¥223.6B (+12.9%), and a margin of 32.2%, sustaining the high-margin structure of the core business. It accounted for 94.8% of revenue, driven by demand for job advertising, recruitment services, and ARPU expansion among existing clients. Operating margin declined 2.6pt from 34.8% as upfront hiring and marketing investments likely increased. The Incubation segment doubled revenue to ¥39.7B (+99.5%) but recorded an operating loss of ¥15.6B (margin △39.2%), widening from a ¥11.7B loss in the prior year. Initial investment burdens and start-up costs associated with rapid growth are heavy, resulting in limited current earnings contribution. Corporate adjustments were △¥11.9B (△¥11.5B prior year), reflecting ongoing corporate-level costs not attributable to segments.
[Profitability] Operating margin 26.8%, Net margin 19.6%, Gross margin 89.5% remain high, though operating margin declined 2.9pt YoY due to growth investments. ROE 17.4% indicates efficient use of equity and decomposes into Net margin 19.6% × Asset turnover 0.65 × Financial leverage 1.37x. [Cash Quality] Contract liabilities ¥151.9B rose +25.2% from ¥121.3B prior year, supporting stable cash inflows under the advance-payment business model. Accounts receivable ¥102.2B increased in line with sales and represents 14.0% of revenue, equivalent to about 1.3 months of sales—a healthy level. Interest coverage (Operating Income ¥196.1B ÷ interest expense ¥0.04B) is approximately 4,900x, making interest burden negligible. [Investment Efficiency] With total assets of ¥1,125.2B and Net Income ¥143.4B, return on assets is 12.7%. Goodwill of ¥139.8B increased by +¥102.4B from ¥37.4B prior year, representing 12.4% of total assets and reflecting accelerated M&A investment. Intangible fixed assets ¥152.7B (13.6% of total assets) indicate accumulation of development spending and acquired assets. [Financial Soundness] Equity ratio 73.2% (improved 2.3pt from 70.9% prior year), current ratio 312%, cash ¥729.3B, and interest-bearing debt ¥1.6B (total) imply a D/E ratio of about 0.02x and effectively debt-free operations.
The cash flow statement was not disclosed; therefore, funding trends are analyzed from balance sheet movements. Cash and deposits were ¥729.3B, a slight increase of +¥1.5B from ¥727.8B prior year, suggesting growth investments absorbed a portion of the ¥143.4B in net income. Contract liabilities increased to ¥151.9B (+¥30.6B from ¥121.3B), indicating continued operating cash inflows from advance payments. Accounts receivable rose to ¥102.2B (+¥30.1B) consistent with revenue expansion, and retained earnings increased to ¥653.8B (+¥142.2B from ¥511.6B), broadly matching current period net income of ¥143.4B; with no dividend, the entire amount was retained. Goodwill increased by +¥102.4B and intangible fixed assets by +¥99.4B, pointing to cash outflows for M&A consideration and development investment. Tangible fixed assets rose to ¥24.8B (+¥3.5B), indicating limited capital expenditures. Interest-bearing debt edged up slightly from ¥1.2B to ¥1.6B, but the absolute amount is negligible, and investments are effectively funded by equity and operating cash.
Earnings quality is high with a predominance of recurring items. Non-operating income ¥18.6B (2.5% of revenue) comprises equity-method investment gains ¥2.4B and other non-operating income ¥0.7B, indicating low dependence on one-off items. Non-operating expenses ¥0.3B (interest expense ¥0.04B, forex losses ¥0.15B, etc.) are minimal. The +9.3% divergence between Ordinary Income and Operating Income reflects a stable contribution from non-operating items. Special gains ¥0.2B represent 0.1% of Ordinary Income and are immaterial. Net Income ¥143.4B results from Ordinary Income ¥214.4B less tax expense ¥71.0B (effective tax rate 33.1%) and non-controlling interests ¥1.2B; no accounting anomalies were observed. Comprehensive income ¥143.3B is nearly identical to Net Income ¥143.4B; other comprehensive income △¥0.1B (translation adjustments +¥0.4B, available-for-sale securities valuation △¥0.4B) had minimal impact, so changes in equity are mainly driven by retained earnings. Under JGAAP, goodwill amortization could compress future profits, and the large goodwill increase this period warrants attention to potential future amortization burdens.
Full Year / FY guidance is Revenue ¥992.0B (+23.7%), Operating Income ¥231.0B (+7.7%), Ordinary Income ¥235.3B (+3.6%), and Net Income ¥160.8B (current period EPS forecast based on 401.05 yen). Progress through the Q3 cumulative period is 73.8% of revenue, 84.9% of operating income, and 91.1% of ordinary income, indicating significant front-loading of profits. Compared with a standard Q3 cumulative progress benchmark of 75%, revenue is 1.2pt low, but Operating Income is +9.9pt and Ordinary Income +16.1pt ahead, reflecting cost control and profitability improvement through H1 and Q3 cumulative. Even accounting for some investment acceleration in H2, visibility to full-year achievement is high, particularly given the front-loading at the ordinary income level which is supported by stable non-operating income. No revisions have been made; confidence in the company plan is maintained.
No interim dividend was paid this period (0 yen), maintaining a dividend suspension; payout ratio is 0% with all earnings retained to preserve growth investment capacity. Given Net Income ¥143.4B, cash ¥729.3B, and interest-bearing debt ¥1.6B, the capacity to pay dividends exists, but priority is given to M&A and pre-emptive investments in the Incubation business associated with goodwill increases. No share buybacks were executed; capital allocation clearly prioritizes business expansion and capital deployment into new areas over shareholder returns. In the future, dividend initiation could be considered depending on profit growth and investment recovery progress, but current capital allocation is focused on internal growth and M&A.
Revenue concentration risk: The HRTech segment accounts for 94.8% of revenue and a large portion of operating income, implying high dependence on a single business. If hiring demand weakens or macro employment conditions deteriorate, the impact on consolidated results would be direct and material. Intensifying competition and price pressure could also compress margins.
Goodwill and intangible asset impairment risk: Goodwill is ¥139.8B (17.0% of equity), and intangible fixed assets are ¥152.7B (13.6% of total assets), both having increased significantly year-on-year. If post-M&A PMI progress falters or KPIs are missed, impairment losses could erode equity and profit. Under JGAAP, continued goodwill amortization could further depress future margins.
Delay in Incubation profitability: Incubation posted Revenue ¥39.7B with an operating loss of ¥15.6B (margin △39.2%), and the deficit widened year-on-year. If investment recovery lags expectations, dilution of consolidated operating margin may persist, potentially reducing ROE and constraining capacity for shareholder returns.
Profitability & Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | 26.8% | 8.2% (3.6%–18.0%) | +18.6pt |
| Net Margin | 19.6% | 6.0% (2.2%–12.7%) | +13.6pt |
Profitability ranks well above peers, highlighting a high gross margin, high return business model.
Growth & Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | 24.3% | 10.4% (-1.1%–19.5%) | +13.9pt |
Revenue growth substantially exceeds the industry median, driven by expansion of the core business and launch of new businesses.
※ Source: Company compilation
The core HRTech’s high-margin structure (gross margin 89.5%, operating margin 32.2%) continues, with hiring demand capture and deeper penetration into existing customers driving growth. Ordinary Income progress at 91.1% of the full-year guidance as of Q3 cumulative is ahead of schedule, increasing the likelihood of meeting the plan. The financial base is extremely strong (cash ¥729.3B, equity ratio 73.2%, effectively debt-free), supporting significant growth investment capacity.
Operating margin declined from 29.7% to 26.8% (-2.9pt) as growth investments and widening Incubation losses temporarily pressured margins. Goodwill rose by +¥102.4B YoY, reflecting accelerated M&A investment; monitoring PMI progress and impairment risk is necessary. The timing of Incubation profitability and progress on revenue diversification will be key to mid-term margin improvement and risk diversification.
This report was automatically generated by AI analyzing XBRL financial statement data. It does not constitute a recommendation to invest in any particular security. Industry benchmarks are reference information compiled by the Company based on public financial statements. Investment decisions are your own responsibility; consult a professional advisor as necessary before making investment decisions.